Literature DB >> 9189032

High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy.

J A Nicoll1, C Burnett, S Love, D I Graham, D Dewar, J W Ironside, J Stewart, H V Vinters.   

Abstract

From the somewhat conflicting published data on apolipoprotein E (apoE) genotype in hemorrhage due to cerebral amyloid angiopathy (CAA), it is unclear whether apoE genotype influences the risk of CAA-related hemorrhage independently of its association with concomitant Alzheimer's disease (AD). We determined the apoE genotypes of 36 patients presenting with cerebral hemorrhage associated with histologically confirmed CAA. The frequency of apoE epsilon 2 was 0.25 and the frequency of apoE epsilon 4 was 0.18. Patients with CAA-related hemorrhage and concomitant AD pathology (CERAD criteria, n = 17) had a high apoE epsilon 4 frequency, close to that in AD cases without hemorrhage. Patients in whom CAA-related hemorrhage occurred in the absence of significant AD pathology (n = 13) had an apoE epsilon 4 frequency somewhat lower than non-AD controls without hemorrhage. However, in CAA-related hemorrhage, the apoE epsilon 2 frequency was high regardless of whether significant AD pathology was present. We conclude that whereas possession of apoE epsilon 2 may be a risk factor for cerebral hemorrhage due to CAA, apoE epsilon 4 is a risk factor for concomitant AD but not an independent risk factor for CAA-related hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9189032     DOI: 10.1002/ana.410410607

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  61 in total

Review 1.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects.

Authors:  G C Chiang; P S Insel; D Tosun; N Schuff; D Truran-Sacrey; S T Raptentsetsang; C R Jack; P S Aisen; R C Petersen; M W Weiner
Journal:  Neurology       Date:  2010-10-27       Impact factor: 9.910

Review 3.  The Inflammatory Form of Cerebral Amyloid Angiopathy or "Cerebral Amyloid Angiopathy-Related Inflammation" (CAARI).

Authors:  Howard S Kirshner; Michael Bradshaw
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 5.081

Review 4.  Treatment targets in intracerebral hemorrhage.

Authors:  Navdeep Sangha; Nicole R Gonzales
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

5.  Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.

Authors:  John M Ringman; Michael C Sachs; Yan Zhou; Sarah E Monsell; Jeffrey L Saver; Harry V Vinters
Journal:  JAMA Neurol       Date:  2014-07-01       Impact factor: 18.302

6.  The distribution of apolipoprotein E alleles in Scottish perinatal deaths.

Authors:  J-C Becher; J W Keeling; N McIntosh; B Wyatt; J Bell
Journal:  J Med Genet       Date:  2005-09-23       Impact factor: 6.318

Review 7.  Apolipoprotein E in Alzheimer's disease and other neurological disorders.

Authors:  Philip B Verghese; Joseph M Castellano; David M Holtzman
Journal:  Lancet Neurol       Date:  2011-03       Impact factor: 44.182

Review 8.  Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence.

Authors:  Yu Yamazaki; Meghan M Painter; Guojun Bu; Takahisa Kanekiyo
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

9.  Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study.

Authors:  Johannes Attems; Florían Lauda; Kurt A Jellinger
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

10.  Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings.

Authors:  Andreas Charidimou; Anant Krishnan; David J Werring; H Rolf Jäger
Journal:  Neuroradiology       Date:  2013-05-25       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.